Morgan Joseph reiterates a 'Buy' rating on Integra LifeSciences (Nasdaq: IART), price target increased from $41 to $51.

Morgan analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE